Pfizer Secures China Nod for Obesity Drug as Generics Loom
China has approved a new obesity treatment from Pfizer Inc., heightening competition in a market poised to become even more crowded with the looming entry of generics.
By Amber Tong · Bloomberg Markets
China has approved a new obesity treatment from Pfizer Inc., heightening competition in a market poised to become even more crowded with the looming entry of generics.